近期部分学术成果

 发布日期:2014-1-30 16:00:00 来源:本站          字体:       打印

1.  Liu GG. et al., “How much does social status matter to health? – evidence from China’s Academician election,” Economics and Human Biology, under second revision, 2014.
 
2.  周钦,刘国恩,“健康冲击:现行医疗保险制度究竟发挥了什么作用?”《经济评论》,2014(5).
 
3.  潘杰,刘国恩,尹庆双,“医疗体制管办分开与服务供”,《经济学报》,2014 (1):33-50.
 
4.  Liu GG and Krumholz S., “Economics of health transition in China,” The Oxford Companion to the Economics of China, edited by Ravi Kanbur et al., Oxford University Press, 2014.
 
5.  Qin XQ, Pan J, and Liu GG., “Does participating in health insurance benefit the migrant workers in China? an empirical investigation,” China Economic Review, 2014 (30): 263-278.
 
6.  DiBonaventura M, Yuan Y, Lescrauwaet B, L'Italien G, Liu GG., “Multicountry burden of chronic hepatitis C viral infection among those aware of their diagnosis: A patient survey,” PLOS ONE, Jan 21, 2014.
 
7.  黄源,刘国恩,刘跃华等,“精神分裂症的疾病经济负担:基于广州医保数据的分析,”《中国卫生经济》,2014(5): 62-65.
 
8.  Wu J., Xu J., Liu GG., “Pharmaceutical pricing: an empirical study of market competition in Chinese hospitals,” PharmacoEconomics, 2014 (32):293-303.
 
9.  兰烯,刘国恩,李林,“医疗机构产权性质对医疗服务质量的影响,”《中国经济问题》,2014(2):67-78.
 
10. Gao C., Xu F., Liu GG., “Payment reform and changes in health care in China,” Social Science & Medicine, 2014 (111): 10-16.
 
11. Chen G, Liu GG., and Xu F., "The impact of the urban resident basic medical insurance in China on health services utilization," PharmacoEconomics, 2014 (32): 277-292.
 
12. Xu J., Liu GG. et al., “A comparison of outpatient healthcare expenditures between public and private medical institutions in urban China: an instrumental variable approach,” Health Economics, 11 Dec, 2013.
 
13. 赵绍阳,臧文斌,傅十和,刘国恩,“强制医保制度下无保险人群的健康状况研究,”《经济研究》,2013 (7): 118-131.
 
14. 刘国恩,“践行三中全会改革要义: 深化国家医改,谨防误读盲区,”《经济科学》,2013年第六期。
 
15. Li H., Liu GG., Glaetzer C., “Financing innovative medicines in China: the role of commercial health insurance,” Chinese Studies, 2013 (3): 128-133.
 
16. Liu GG., Chen YQ, and Qin XZ., “Transforming rural healthcare through information technology: an interventional study in China,” Health Policy and Planning, Oct 30, 2013.
 
17. Pan J., Liu GG., and Gao C., “How does separating government regulatory and operational control of public hospitals matter to healthcare supply?” China Economic Review, 2013 (27):1–14.
 
18. 伍红艳,刘国恩,“生命质量量表不同计分方法对评价结果的影响,”《中国卫生经济》,2013 (8).
 
19. 刘国恩,“转变经济发展方式靠什么:论两只看不见的手,”《比较》,2013 (3):130-144.
 
20. Lai W, Hu S., Hou J, Liu GG., “A novel estimation of the impact of treatment with entecavir on long-term mortality, morbidity and healthcare costs of chronic hepatitis B in China,” Value in Health Regional Issues, 2013 (2):48-56.
 
21. 樊敏杰,刘国恩,李林, “医疗机构产权性质对医疗费用的影响,”《中国经济问题》,2013 (5):59-69.
 
22. 刘国恩,官海静,高晨,“中国社会办医的现状分析,”《中国卫生政策研究》,2013(6):41-46.
 
23. Pan J, Qin X, Liu GG., "The impact of body size on urban employment: evidence from China." China Economic Review, 2013 (27): 249-263
 
24. Luo N, Li M, Liu GG et al., “Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach,” Quality of Life Research, 2013(4): 885–890.
 
25. 潘杰,雷晓燕,刘国恩,“医疗保险促进健康吗?”《经济研究》,2013 (4): 130-142.
 
26. Qin XZ and Liu GG., “Does the U.S. healthcare safety net discourage private insurance coverage?” European J of Health Economics, 2013 (3): 457-469.
 
27. Liu YJ, Xue YJ, Liu GG., and Ma AX., "Development of foreign invested hospitals in China: obstacles and coping strategies," Journal of Hospital Administration, 2013(2): 142-150.
 
28. Zhao ZY, Liu GG., et al., “Hospital costs of adverse events in patients with metastatic colorectal cancer,” Journal of Cancer Therapy, 2013 (4): 153-158.
 
29. 符一男,刘国恩,朱琳,马爱霞,“七价肺炎结合疫苗的药物经济学评价,”《中国卫生经济》, 2013(1).
 
30. 官海静,刘国恩,熊先军, “城镇居民基本医疗保险对住院服务利用公平性的影响,”《中国卫生经济》,2013(1).

31. 高月霞,徐程, 《另辟蹊径---淮安总额控制下按病种分值结算方式改革》,《中国社会保障》,2013(4).

32. 高月霞,倪倬健,李小杉, 《1989-2009年海门市糖尿病死亡分析及预测》,《中国卫生统计》,2013(1).

33. 高月霞,李奕辰,宗蕾, 《南通市高血压健康知识及影响因素分析》,《中国公共卫生》,2013(4).

34. 高月霞,李奕辰,刘国恩, 《基本药物制度对南通市社区卫生服务机构门诊合理用药的影响研究》,《中华医院管理杂志》,2013(7).

35. 高月霞,徐程,刘国恩, 《社会支持对老年人健康相关生命影响的研究—基于南通的实证》,《人口与发展》,2013(3).

36. Wu EQ, Xie JP, Liu GG., ”Trend in economic burden of diabetes in urban china from 2009 to 2011 ,”New Orleans: ISPOR 18th Annual International Meeting, 2013.

37. 官海静,刘国恩,熊先军,《中国城镇居民的健康公平和健康绩效》,《中国卫生经济》, 2013(9).

38. 程迪尔,官海静,刘国恩,2013:《生活水平指标选择对健康公平测算结果的影响》,《中国卫生经济》, 2013(3).

39. 孙艳坤,刘国恩,李幼平,2013:《化疗与利妥昔单抗联用治疗非霍奇金淋巴瘤的药物经济学系统评价》,《中国循证医学》, 2013(13).

40. 周钦, 臧文斌,刘国恩, 2013:《医疗保障水平与中国家庭的医疗经济风险》,《保险研究》, 2013(7).

41. 朱琳,刘国恩,《小儿肺炎疫苗的卫生经济学评价》,《中国卫生经济》, 2013(4).

42. 刘明,孙利华,《城镇居民五种主要慢病人群家庭经济风险的比较研究—基于全国9个城市的微观证据》,《亚洲社会药学》,2013.
 
43. 房珊杉,徐程,刘国恩,赵绍阳,“城镇居民基本医疗保险参保决策中搭便车动机的研究,”.《保险研究》,2012(7):111-120.
 
44. 臧文斌,赵绍阳,刘国恩,“城镇基本医疗保险中逆向选择的检验,”《经济学季刊》,2012, 12(1):47-70.
 
45. 薛新东,刘国恩,“社会资本决定健康状况吗?”《财贸经济》,2012(8):113-121 。
 
46. Liu GG et al., “The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan,” Value in Health, 2012, 15(1).
 
47. 徐程,尹庆双,刘国恩,“健康经济学研究新进展,”《经济学动态》,2012(9):120-127.
 
48. 藏文斌,刘国恩,徐菲,“中国城镇基本医疗保险对家庭消费的影响,”《经济研究》,2012(7):75-85。
 
49. 谭婧,刘国恩等,“昆明试点医师多点执业实施效果的实证分析,”《中华医院管理杂志》2012,4:241-245.
 
50. 胡宏伟,刘国恩,“城镇居民医疗保险对国民健康的影响效应与机制,”《南方经济》,2012(10):186-199.

51. 高月霞,孙华,刘国恩, 2012:《尿毒症透析治疗的价格谈判机制研究》,《社会保障研究》, 2012(1).

52. 刘明,刘国恩,2012:《药物经济学在药品定价中应用的定位分析》,《中国药物经济学》, 2012(6).

53. 臧文斌, 赵绍阳, 刘国恩, 《城镇基本医疗保险中逆向选择的检验》,《经济学(季刊)》, 2012(1).

54. 肖静,高月霞,刘国恩, 2012:《6168例肝癌患者住院费用影响因素的通径分析》,《中国卫生经济》, 2012(1).
 
55. 秦学征,刘国恩, “医疗保险对劳动力市场的影响:综述分析,”《经济学动态》, 2011(12):116-121。
 
56. Pan Jay and Liu GG, “The determinants of Chinese provincial government health expenditures: evidence from 2002-2006 data,” Health Economics, 2012(21): 757–777.
 
57. 刘国恩,王钊,鲍怡倩,李洪,“我国农村育龄妇女乙肝预防教育干预效果研究,”《中国卫生经济》,2011, 30(5).
 
58. 潘杰,秦学征,刘国恩,“体形对城市劳动力就业的影响,” 《南开经济研究》,2011;
 
59. 刘国恩,蔡春光, 李林, “中国老人医疗保障与医疗服务需求的实证分析,”《经济研究》,2011(3): 95-107.
 
60. 刘国恩,常精华等, “中医药治疗非小细胞肺癌的经济计量分析—中国广州的实证,” 《中国药学杂志》, 2011 (04)。
 
61. 潘杰,徐菲,刘国恩,臧文斌,“台湾地区全民健康保险制度建立对内地医改的启示,”《中国卫生经济》,2011 (07)。
 
62. 吴晶,刘国恩,“中国药品价格和数量指数及偏倚的实证分析,”《中国药物经济学》,2011 (01)。

63. 潘杰,《护理费上涨语境下的管办分开》,《中国社会保障》, 2011(2).

64. 潘杰,《多点执业受阻”人事藩篱”》,《中国社会保障》, 2011(4).

65. 王鹏,刘国恩,《我国城镇居民病伤治疗措施选择的影响因素分析》,《中国卫生经济》, 2011(9).

66. 王弈冬,岳晓萌,吴久鸿,《药物相关问题的国际监测干预与经济性分析》,《中国药物应用与监测》, 2011(3).
 
67. 林莞娟,刘国恩等,“中国城镇居民基本医疗保险实施与评价,”《经济学报》,2010.
 
68. 甘犁,刘国恩,马 双, “基本医疗保险对促进家庭消费的影响,”《经济研究》,2010.
 
69. 潘杰,刘国恩, “卫生体制“管办”怎么分?”《中国社会保障》, 2010年9月.
 
70. 王鹏,刘国恩, “健康人力资本与性别工资差异,”《南方经济》,2010年(9):73-84.
 
71. Qiu Y., Fu A, Liu GG., and Christensen D., “Healthcare Costs of Atypical Antipsychotic Use for Patients with Bipolar Disorder in a Medicaid Program,” Applied Health Economics and Health Policy, 2010, 8(3):167-177.
 
72. Liu GG., Zhang SF ,and Zhang ZY., Investing in Human Capital for Economic Development in China, published by World Scientific, 2010.

73. 朱琳,孙利华,刘国恩, 《关于药品招标中质量分层的思考》,《中国药房》,2010(13).

74. 李洪超,张银花,刘国恩, 《糖尿病治疗指标终点综述与复合重点的权重构建》,《中国药物经济学》, 2010(2).

75. 李明晖,刘国恩,马爱霞, 《中国城乡居民健康相关生存质量研究》,《中国药物经济学》, 2010(3).

76. 李强,臧文斌, 《父母外出对留守儿童健康的影响》,《经济学(季刊)》, 2010(1).

77. 刘国恩, 《医改评估要看结果》,《中国医院院长》, 2010(19).

78. 赵绍阳, 《疾病冲击与非完全消费保险》,《中国人口科学》, 2010(5).

79. 朱琳,孙利华,刘国恩, 《关于药品招标中质量分层的思考》,《中国药房》, 2010(40).
 
80. Liu GG., Fukuda T., Lee CE. et al., “Evidenced-based Decision Making on Medical Technologies in China, Japan, and Singapore,” Value in Health, 2009, 12(3): S12 - S17.
 
81. 刘国恩, “全民医疗保障与保民生促增长,” 《理论前沿》, 2009, 16: 5-8.
 
82. Liu GG., Li L., Hou X. et al., “The role of for-profit hospitals in medical expenditures:  evidence from
aggregate data in China,” China Economic Review, 2009, 20: 625-633.
 
83. Lin W., Liu GG., and Chen G., “The Urban Resident Basic Medical Insurance: a landmark reform towards universal coverage in China,” Health Economics, 2009, 18:S83-S96.
 
84. Liu GG., “Beijing’s perspective: the internal debate on health care reform,” published by the Center for Strategy and International Studies (CSIS), Washington DC., 2009.
 
85. 刘国恩,唐燕,刘立藏,“城镇职工医疗保险政策研究:个人账户与医疗支出,”《财经科学》,2009.
 
86. 刘国恩,唐婷婷,刘立藏,“医疗保险个人账户对医疗支出的影响:基于镇江医保数据的面板分析,”《中国卫生经济》,2009.
 
87. Qiu Y, Christensenb D, Fu AZ, and Liu GG., “Cost analysis in a Medicaid program for patients with bipolar disorder who initiated atypical antipsychotic monotherapy,” Current Medical Research and Opinion, 2009, 25(2): 351–361.

88. 朱琳,刘美娟, "肺炎链球菌性疾病流行病学及小儿肺炎疫苗的综述",《亚洲社会药学》, 2009(2).
 
89. 李林,刘国恩,“我国营利性医院发展与医疗费用研究,”《管理世界》,2008, 10: 53-63.
 
90. 胡善联, 刘国恩等,“我国糖尿病流行病学和疾病经济负担研究现状,”《中国卫生经济》,2008(8):5-8.
 
91. Liu GG., Eggleston K., and Hu TW., “Emerging health economics and outcomes research in Asian Pacific Region,” Value in Health, 2008, 11:s1-s2.
 
92. Liu GG., Dow W., Fu AZ., Akin J., and Lance P., “Income productivity in China: on the role of health,” Journal of Health Economics, 2008, 22: 22-44.

 
Copyright© 1998-2010 北京大学 国家发展研究院 北京大学中国卫生经济研究中心 版权所有,京ICP备05005746
保留所有权利,不经允许请勿挪用,有任何问题与建议请联络:webmaster@nsd.pku.edu.cn